ArticleNucleic acids research2026
MetabFlow: a comprehensive metabolic map for exogenous natural products.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Exogenous natural products (NPs) undergo complex metabolic transformations both in vivo and in vitro, generating structurally diverse metabolites. Due to the involvement of host enzymes and gut microbiota, as well as the structural complexity of NPs themselves, their metabolic processes exhibit unique characteristics. However, existing metabolic transformation information remains fragmented, limiting systematic understanding of their metabolic mechanisms. To address this gap, MetabFlow (https://bddg.hznu.edu.cn/metabflow/), a comprehensive database dedicated to the metabolism of exogenous NPs, was developed. MetabFlow is distinguished by: (a) systematic integration of 7294 curated metabolic reactions covering both in vivo and in vitro transformations, providing a complete knowledge map of exogenous NP metabolism; (b) unique integration of enzyme-catalyzed and microbiota-mediated reactions, highlighting the distinctive metabolic features of NPs; (c) establishment of a structured metabolic network by constructing upstream-downstream reaction relationships, elucidating how exogenous NPs evolve across different metabolic pathways; (d) inclusion of approximately 3200 compounds not indexed in mainstream databases, with detailed structural information, annotations, and complete metabolic profiles. MetabFlow is designed to support research in NP metabolism, drug discovery, and related fields.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.